These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38146680)

  • 41. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis.
    Caraballo C; DeFilippis EM; Nakagawa S; Ravindra NG; Miller PE; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Mullan C; Ali A; Maurer MS; Desai NR; Ahmad T; Topkara VK
    JACC Heart Fail; 2019 Dec; 7(12):1069-1078. PubMed ID: 31779930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-operative sarcopenia is predictive of recurrent gastrointestinal bleeding on left ventricular assist device support: A multicenter analysis.
    Klajda M; Trachtenberg B; Araujo R; Estep JD; Masotti M; Teigen L; Schultz J; John R; Martin C; Suarez EE; Cogswell R
    J Heart Lung Transplant; 2022 Jun; 41(6):757-762. PubMed ID: 35105490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of body composition in patients with digestive tract cancers: A prospective cohort study of 8,267 adults from China.
    Han J; Liu X; Wang J; Tang M; Xu J; Tan S; Liu X; Wu G
    Clin Nutr ESPEN; 2024 Aug; 62():192-198. PubMed ID: 38901941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pericardial Adipose Tissue Volume and Left Ventricular Assist Device-Associated Outcomes.
    Rao VN; Obeid MJ; Rigiroli F; Russell SD; Patel CB; Molinger J; Gupta RT; Agarwal R; Fudim M
    J Card Fail; 2022 Jan; 28(1):149-153. PubMed ID: 34274515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation.
    Salna M; Garan AR; Kirtane AJ; Karmpaliotis D; Green P; Takayama H; Sanchez J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):499-506. PubMed ID: 31986207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
    Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
    Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Durable left ventricular assist device implantation in extremely obese heart failure patients.
    Lee AY; Tecson KM; Lima B; Shaikh AF; Collier J; Still S; Baxter R; DiMaio JM; Felius J; Carey SA; Gonzalez-Stawinski GV; Nauret R; Wong M; Hall SA; Joseph SM
    Artif Organs; 2019 Mar; 43(3):234-241. PubMed ID: 30357882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of preoperative versus postoperative dialysis on left ventricular assist device outcomes: An analysis from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support database.
    Mehaffey JH; Cantor R; Myers S; Teman NR; Kern JA; Ailawadi G; Pagani F; Kirklin J; Yount K; Yarboro L
    JTCVS Open; 2022 Mar; 9():122-143. PubMed ID: 36003469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Less invasive left ventricular assist device implantation may reduce right ventricular failure.
    Pasrija C; Sawan MA; Sorensen E; Voorhees H; Shah A; Strauss E; Ton VK; DiChiacchio L; Kaczorowski DJ; Griffith BP; Pham SM; Kon ZN
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):592-598. PubMed ID: 31326991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis.
    Taleb I; Wever-Pinzon J; Wang W; Koliopoulou A; Dranow E; Yu T; Yin L; McKellar SH; Stehlik J; Fang JC; Wever-Pinzon O; Selzman CH; Drakos SG
    Heart Lung Circ; 2020 Aug; 29(8):1226-1233. PubMed ID: 32085955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications.
    Papathanasiou M; Mincu RI; Lortz J; Horacek M; Koch A; Pizanis N; Kamler M; Rassaf T; Luedike P
    ESC Heart Fail; 2019 Jun; 6(3):545-551. PubMed ID: 30861636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity.
    Kripa E; Rizzo V; Galati F; Moffa G; Cicciarelli F; Catalano C; Pediconi F
    Front Oncol; 2022; 12():987012. PubMed ID: 36212446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients.
    Lamba HK; Kim M; Santiago A; Hudson S; Civitello AB; Nair AP; Loor G; Shafii AE; Liao KK; Chatterjee S
    J Artif Organs; 2022 Mar; 25(1):16-23. PubMed ID: 33982206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.